Literature DB >> 2755078

Retention of glomerular basement membrane-proteoglycans accompanying loss of anionic site staining in experimental diabetes.

D M Templeton1.   

Abstract

The occurrence of heparan sulfate proteoglycan anionic site staining in the glomerular basement membranes of healthy and streptozotocin-induced diabetic rats was investigated. After 12 weeks diabetes, a marked loss of staining by ruthenium red was observed, compared with the age-matched controls. However, extraction and quantitation of total proteoglycan from the glomerular basement membrane revealed no significant differences between the two groups, in terms of absolute yield of glycosaminoglycan, when the latter is expressed per glomerulus. Glomerular basement membranes from both groups become thicker in an age-dependent manner, although they do so at a faster rate in the diabetic group, and a higher collagen content is found in the diabetic membrane at 12 weeks. Thus when proteoglycan content is expressed per mass protein, relative decreases are observed in diabetes. Similarly, a relative but not absolute decrease in proteoglycan content was observed in glomerular basement membranes from spontaneously diabetic BB rats with diabetes of 12 weeks duration. Glycosaminoglycans isolated from control and diabetic glomerular basement membrane have similar characteristics on ion exchange chromatography, to each other, and to newly sulfated, intact glomerular proteoglycans labelled in vitro. We conclude that loss of anionic site staining with ruthenium red in early diabetes is not a consequence of absolute loss or undersulfation of heparan sulfate proteoglycan but reflects structural or biochemical changes in the diabetic matrix.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2755078

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  7 in total

Review 1.  Autocrine and paracrine mechanisms in the early stages of diabetic nephropathy.

Authors:  G Pugliese; F Pricci; G Romeo; G Leto; L Amadio; C Iacobini; U Di Mario
Journal:  J Endocrinol Invest       Date:  1999-10       Impact factor: 4.256

2.  Reduction of heparan sulphate-associated anionic sites in the glomerular basement membrane of rats with streptozotocin-induced diabetic nephropathy.

Authors:  J van den Born; A A van Kraats; M A Bakker; K J Assmann; H B Dijkman; J A van der Laak; J H Berden
Journal:  Diabetologia       Date:  1995-10       Impact factor: 10.122

3.  Increased hyaluronan production in the glomeruli from diabetic rats: a link between glucose-induced prostaglandin production and reduced sulphated proteoglycan.

Authors:  P Mahadevan; R G Larkins; J R Fraser; A J Fosang; M E Dunlop
Journal:  Diabetologia       Date:  1995-03       Impact factor: 10.122

4.  Selective proteinuria in diabetic nephropathy in the rat is associated with a relative decrease in glomerular basement membrane heparan sulphate.

Authors:  J van den Born; A A van Kraats; M A Bakker; K J Assmann; L P van den Heuvel; J H Veerkamp; J H Berden
Journal:  Diabetologia       Date:  1995-02       Impact factor: 10.122

5.  Poly-L-lysine-gold probe for the detection of anionic sites in normal glomeruli and in idiopathic and experimentally-induced nephrosis. A comparative ultrastructural study.

Authors:  P Russo; D Gingras; M Bendayan
Journal:  Am J Pathol       Date:  1993-01       Impact factor: 4.307

6.  The assessment of early glycosaminoglycan concentration changes in the kidney of diabetic rats by critical electrolyte concentration staining.

Authors:  Mohsen Pourghasem; Ebrahim Nasiri; Shima Sum; Hamid Shafi
Journal:  Int J Mol Cell Med       Date:  2013

7.  The protective role of fucosylated chondroitin sulfate, a distinct glycosaminoglycan, in a murine model of streptozotocin-induced diabetic nephropathy.

Authors:  Conrado L R Gomes; Cristina L Leão; Carolina Venturotti; André L Barreira; Gabriela Guimarães; Roberto J C Fonseca; Rodrigo S Fortunato; Paulo A S Mourão; Alvimar G Delgado; Christina M Takiya; Maurilo Leite
Journal:  PLoS One       Date:  2014-09-05       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.